Tango Therapeutics (NASDAQ:TNGX – Free Report) had its price objective lowered by Barclays from $18.00 to $13.00 in a report published on Friday morning, Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other equities analysts have also recently commented on TNGX. Cantor Fitzgerald initiated coverage on shares of […]
Nuvation Bio Inc. (NYSE:NUVB – Free Report) – HC Wainwright increased their Q2 2024 earnings per share estimates for shares of Nuvation Bio in a note issued to investors on Wednesday, May 22nd. HC Wainwright analyst R. Burns now anticipates that the company will earn ($0.07) per share for the quarter, up from their prior […]
Benchmark reissued their buy rating on shares of Canoo (NASDAQ:GOEV – Free Report) in a research report report published on Wednesday morning, Benzinga reports. The firm currently has a $5.00 price objective on the stock. Several other research firms have also recently issued reports on GOEV. Stifel Nicolaus cut their price objective on shares of […]
Benchmark reaffirmed their buy rating on shares of Canoo (NASDAQ:GOEV – Free Report) in a research note published on Wednesday morning, Benzinga reports. They currently have a $5.00 price objective on the stock. GOEV has been the subject of a number of other reports. HC Wainwright reissued a buy rating and issued a $7.00 target […]
StockNews.com upgraded shares of Pixelworks (NASDAQ:PXLW – Free Report) from a sell rating to a hold rating in a report released on Tuesday. A number of other brokerages have also weighed in on PXLW. Needham & Company LLC cut their target price on shares of Pixelworks from $3.50 to $2.50 and set a buy rating […]